• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW 1.72% 3.0¢

ACTINOGEN MEDICAL LIMITED

Actinogen Medical Limited is an Australia-based biotechnology company. The Company is... Actinogen Medical Limited is an Australia-based biotechnology company. The Company is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The Company is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. It has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The Company conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ACW 25/04/24 20 5.3K
25/04/24 Last post  Lait Comments Created with Sketch.  20  Views Created with Sketch.  5.3K 
ACW
News: ACW Enrolment Completed In Actinogen's XanaCIDD Phase 2A Cognition & Depression Trial
22/04/24 0 163
22/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  163 
ACW 22/04/24 1 615
TRENDING NEWS

Hillcrest's ZVS Technology Gains Traction in New Applications, Fuels Growth

NEWS
26 Apr 2024
22/04/24 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  615 
ACW 15/04/24 0 192
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  192 
ACW
Are Biotech stocks the next move?
12/04/24 28 9.5K
12/04/24 Last post  revolution Comments Created with Sketch.  28  Views Created with Sketch.  9.5K 
ACW 06/04/24 4 2.4K
06/04/24 Last post  revolution Comments Created with Sketch.  4  Views Created with Sketch.  2.4K 
ACW 05/04/24 0 285
05/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  285 
ACW 05/04/24 0 188
05/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  188 

See All Discussions arrow Created with Sketch.

Timeline

ACW completes cognition & depression phase 2 trial enrolment
22 Apr 09:14
 
First patient treated in ACW XanaMIA ph 2b Alzheimers trial
15 Apr 09:05
 
Notification of cessation of securities - ACW
15 Apr 08:34
 
Appendix 3Y-Mr Malcolm McComas
05 Apr 08:49
 
Notification of cessation of securities - ACW
05 Apr 08:47
 
Application for quotation of securities - ACW
03 Apr 11:18
 
View More arrow Created with Sketch.
(20min delay)
Last
3.0¢
Change
0.001(1.72%)
Mkt cap ! $68.64M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $2.127K 72.09K

Buyers (Bids)

No. Vol. Price($)
10 2936100 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 77676 4
View Market Depth
Last trade - 11.12am 26/04/2024 (20 minute delay) ?
Last
2.9¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
3.0¢ 3.0¢ 2.9¢ 470000
Last updated 11.40am 26/04/2024 ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.